KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Tuesday
Mar252014

NCT02097849

A Phase 3b Study of BG00012's Effect on Vaccination Response in Subjects With Relapsed Forms of Multiple Sclerosis

A Randomized, Open-Label Study to Assess the Effects of BG00012 on the Immune Response to Vaccination and on Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

Conditions: Mulitple Sclerosis
Sponsor: Biogen Idec
Phase  III

Tuesday
Mar042014

NCT02079480

Study to Evaluate the Safety, Tolerability, PK, and PD of CD40 in Healthy Subjects (CD40 FIH)

Condition: n/a  (Healthy Adults)
Sponsor: Bristol-Myers Squibb
Phase I

Wednesday
Jan012014

NCT02031198

18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease (FUNDAMANT)

Condition: Alzheimer's Disease
Sponsor: Axon Neuroscience SE
Phase I

Tuesday
Jul232013

NCT01911234

Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis 

Condition: Rheumatoid Arthritis
Sponsor: NeoVacs
Phase: II 

Tuesday
May072013

NCT01850238

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Condition: Alzheimer's Disease
Sponsors: Axon Neuroscience
Phase: I 

Thursday
Feb142013

NCT01910662

Friday
Nov232012

NCT01741038

Study of AlloStim In-Situ Vaccine in Pre-Treated Metastatic Breast Cancer

Condition: Breast Cancer
Sponsors: Immunovative Therapies
Phase 2
Phase 3 

Tuesday
Jul172012

NCT01644968

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I 

Relates to article in Cancer Research

Monday
Jun042012

2011-001232-27

Friday
Mar092012

NCT01552681

Baminercept in Sjögren's Syndrome

Conditions: Sjögren's Syndrome
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase: II